Yoshikatsu Eto - Concepedia

Author

Yoshikatsu Eto

Jikei University School of Medicine

Also Known As

Elizabeth Braunlin, Eto Yoshikatsu, Y Eto, Y. Eto, YOSHIKATSU ETO, YoshiKatsu Eto, Yoshikatsu ETO, Yoshikatsu Eto

316

Publications

6.1K

Citations

H-Index

219

Concepts

All Affiliations

Jikei University School of Medicine National Center For Child Health and Development Saitama Children's Medical Center Tottori University

About

Yoshikatsu Eto is an author at Jikei University School of Medicine specializing in medicine, pathology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	89	3.6K
2	Health Sciences	8	8	514
3	Public Health	4	4	151
4	Natural Sciences	3	3	213
5	Arts	1	1	13

Yoshikatsu Eto

146

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues Takashi Yokoo, Toya Ohashi, Jin Song Shen, Proceedings of the National Academy of Sciences Tissue EngineeringRegenerationAdult Stem CellRodent Whole-embryo CultureOrgan Development	2005	223
A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Molecular Therapy ImmunologyNeurochemical BiomarkersPharmacotherapyCerebral Vascular RegulationNeuroinflammation	2020	159
Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial Torayuki Okuyama, Yoshikatsu Eto, Norio Sakai, Molecular Therapy Phase 1/2Translational MedicineAutoimmune DiseaseMedicineExperimental Neuropathology	2018	150
Japan Elaprase® Treatment (JET) study: Idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II) Torayuki Okuyama, Akemi Tanaka, Yasuyuki Suzuki, Molecular Genetics and Metabolism Attenuated Hunter SyndromePathogenesisJapan Elaprase® TreatmentPathologyMps Ii	2009	144
N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease Hou Lin, Yuko Sugimoto, Yuki Ohsaki, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Gaucher DiseaseBiochemistryGlycosylationMedicineNatural Sciences	2004	125
Diagnostic utility of whole exome sequencing in patients showing cerebellar and/or vermis atrophy in childhood Chihiro Ohba, Hitoshi Osaka, Mizue Iai, Neurogenetics Developmental AnomalyRare DiseasesMendelian DisorderDiagnostic UtilityGenetic Disorder	2013	120
Adenovirus-mediated gene transfer and expression of human β-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice Toya Ohashi, Kazuhiko Watabe, Keiko Uehara, Proceedings of the National Academy of Sciences	1997	109
Cholesterol ester metabolism in the brain: Properties and subcellular distribution of cholesterol-esterifying enzymes and cholesterol ester hydrolases in adult rat brain Yoshikatsu Eto, Kunihiko Suzuki Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism OxysterolLipid SynthesisBiochemistryLipid MetabolismAdult Rat Brain	1971	96
Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse Xing‐Li Meng, Jin‐Song Shen, Toya Ohashi, Journal of Neuroscience Research	2003	94
The incidence of thanatophoric dysplasia mutations inFGFR3 gene is higher in low-grade or superficial bladder carcinomas Takahiro Kimura, Hideaki Suzuki, Toya Ohashi, Cancer	2001	91

Page 1